One of the big banks share platforms had a story dated 10 August 2022 giving Starpharma a plug. Nothing really new in the story, however could have something to do with the SP volatility.
The introductory paragraph in part stated - ... viewed as cheap by the analysts that follow them, and each of them has big potential global markets that they’re working to tap.
I tried to post, however got moderated for advertising as story contains a couple of other stocks.
SPL Price at posting:
76.5¢ Sentiment: Buy Disclosure: Held
